141 related articles for article (PubMed ID: 37482596)
1. Peritoneal Cell-Free DNA: A Novel Biomarker for Recurrence in Pancreatic Cancer.
Sickels A; Jain T; Dudeja V
Ann Surg Oncol; 2023 Oct; 30(11):6308-6310. PubMed ID: 37482596
[No Abstract] [Full Text] [Related]
2. Peritoneal Lavage Tumor DNA as a Novel Biomarker for Predicting Peritoneal Recurrence in Pancreatic Ductal Adenocarcinoma.
Suenaga M; Fujii T; Yamada S; Hayashi M; Shinjo K; Takami H; Niwa Y; Sonohara F; Shimizu D; Kanda M; Kobayashi D; Tanaka C; Nakayama G; Koike M; Fujiwara M; Kondo Y; Kodera Y
Ann Surg Oncol; 2021 Apr; 28(4):2277-2286. PubMed ID: 32875467
[TBL] [Abstract][Full Text] [Related]
3. Peritoneal Cell-Free Tumor DNA is a Biomarker of Locoregional and Peritoneal Recurrence in Resected Pancreatic Ductal Adenocarcinomas.
Leick KM; Tomanek-Chalkley A; Coleman KL; Chan CHF
Ann Surg Oncol; 2023 Oct; 30(11):6652-6660. PubMed ID: 37303025
[TBL] [Abstract][Full Text] [Related]
4. Impact of Tumor-Derived DNA Testing in Peritoneal Lavage of Pancreatic Cancer Patients with and Without Occult Intra-Abdominal Metastases.
Chiba K; Hata T; Mizuma M; Masuda K; Aoki S; Takadate T; Kawaguchi K; Nakagawa K; Morikawa T; Motoi F; Furukawa T; Unno M
Ann Surg Oncol; 2022 Apr; 29(4):2685-2697. PubMed ID: 34739641
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-593-3p Expression in Peritoneal Lavage Fluid as a Prognostic Marker for Pancreatic Cancer Patients Undergoing Staging Laparoscopy.
Hata T; Mizuma M; Masuda K; Chiba K; Ishida M; Ohtsuka H; Nakagawa K; Morikawa T; Kamei T; Unno M
Ann Surg Oncol; 2021 Apr; 28(4):2235-2245. PubMed ID: 33393045
[TBL] [Abstract][Full Text] [Related]
6. EIPL (extensive intraoperative peritoneal lavage) therapy significantly reduces peritoneal recurrence after pancreatectomy in patients with pancreatic cancer.
Yamamoto K; Shimada S; Hirota M; Yagi Y; Matsuda M; Baba H
Int J Oncol; 2005 Nov; 27(5):1321-8. PubMed ID: 16211228
[TBL] [Abstract][Full Text] [Related]
7. Subclinical cancer cell dissemination in peritoneal lavage fluid detected by reverse-transcription polymerase chain reaction identifies patients at high risk for peritoneal recurrence and consequent impaired survival in the setting of preoperative chemoradiation therapy for pancreatic cancer.
Takahashi H; Akita H; Wada H; Tomokuni A; Asukai K; Takahashi Y; Yanagimoto Y; Matsunaga T; Sugimura K; Yamamoto K; Nishimura J; Yasui M; Omori T; Miyata H; Yamamoto T; Nakanishi M; Shirayanagi M; Yamasaki T; Ohue M; Yano M; Sakon M; Ishikawa O
Surgery; 2018 Dec; 164(6):1168-1177. PubMed ID: 30146098
[TBL] [Abstract][Full Text] [Related]
8. Should Positive Cytology Revealed by Intraoperative Lavage Preclude Radical Resection in Resectable Pancreatic Cancer?: A Systemic Review and Meta-analysis.
Li BQ; Wang HY; Li L; Jiang B; Ma CL; Yuan CH; Xiu DR
Pancreas; 2022 Nov-Dec 01; 51(10):1263-1276. PubMed ID: 37099766
[TBL] [Abstract][Full Text] [Related]
9. Value of peritoneal cytology in potentially resectable pancreatic cancer.
Yamada S; Fujii T; Kanda M; Sugimoto H; Nomoto S; Takeda S; Nakao A; Kodera Y
Br J Surg; 2013 Dec; 100(13):1791-6. PubMed ID: 24227366
[TBL] [Abstract][Full Text] [Related]
10. [A Case Report of Pancreatic Tail Carcinoma with Positive Periotoneal Washing Cytology with Recurrence-Free Survival after Surgery and Chemotherapy].
Taida S; Owada Y; Okazaki T; Manabe Y; Nakanishi R; Tachibana T; Tokuhara K; Tsuneki T; Ikeda T; Hosono M; Sendo H
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1982-1984. PubMed ID: 38303272
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of circulating tumor DNA as a biomarker in pancreatic cancer with liver metastasis.
Uesato Y; Sasahira N; Ozaka M; Sasaki T; Takatsuki M; Zembutsu H
PLoS One; 2020; 15(7):e0235623. PubMed ID: 32614932
[TBL] [Abstract][Full Text] [Related]
12. RT-PCR of peritoneal washings predicts peritoneal pancreatic cancer recurrence.
Sato K; Mori R; Hiroshima Y; Oba MS; Matsuyama R; Bouvet M; Hoffman RM; Endo I
J Surg Res; 2018 Jun; 226():122-130. PubMed ID: 29661277
[TBL] [Abstract][Full Text] [Related]
13. Implications of peritoneal lavage cytology in resectable left-sided pancreatic cancer.
Iwagami Y; Eguchi H; Wada H; Tomimaru Y; Hama N; Kawamoto K; Kobayashi S; Mori M; Doki Y; Nagano H
Surg Today; 2015 Apr; 45(4):444-50. PubMed ID: 24975140
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Impact of Positive Peritoneal Lavage Cytology on Resectable Pancreatic Body and Tail Cancer: A Retrospective Study.
Mashiko T; Ogasawara T; Masuoka Y; Ei S; Takahashi S; Hirabayashi K; Mori M; Koyanagi K; Yamamoto S; Nakagohri T
World J Surg; 2023 Mar; 47(3):729-739. PubMed ID: 36357802
[TBL] [Abstract][Full Text] [Related]
15. [Immunocytologic detection of disseminated tumor cells in the peritoneal cavity and bone marrow in patients with pancreatic carcinoma].
Juhl H; Kalthoff H; Krüger U; Schott A; Schreiber HW; Henne-Bruns D; Kremer B
Chirurg; 1994 Dec; 65(12):1111-5. PubMed ID: 7851144
[TBL] [Abstract][Full Text] [Related]
16. Cell-Free DNA Methylation: The New Frontiers of Pancreatic Cancer Biomarkers' Discovery.
Brancaccio M; Natale F; Falco G; Angrisano T
Genes (Basel); 2019 Dec; 11(1):. PubMed ID: 31877923
[TBL] [Abstract][Full Text] [Related]
17. Predicting positive peritoneal cytology in pancreatic cancer.
O'Halloran EA; Board T; Lefton M; Devarajan K; Dotan E; Meyer J; Reddy SS
J Cancer Res Clin Oncol; 2021 Jun; 147(6):1825-1832. PubMed ID: 33389074
[TBL] [Abstract][Full Text] [Related]
18. [Free intraperitoneal tumors cells in pancreatic cancer--significance for clinical course and therapy].
Heeckt P; Safi F; Binder T; Büchler M
Chirurg; 1992 Jul; 63(7):563-7. PubMed ID: 1380421
[TBL] [Abstract][Full Text] [Related]
19. Increased levels of circulating circular RNA (hsa_circ_0013587) may serve as a novel biomarker for pancreatic cancer.
Xu K; Qiu Z; Xu L; Qiu X; Hong L; Wang J
Biomark Med; 2021 Aug; 15(12):977-985. PubMed ID: 34289738
[No Abstract] [Full Text] [Related]
20. Implications of fine-needle aspiration in patients with resectable pancreatic cancer.
Johnson DE; Pendurthi TK; Balshem AM; Ross E; Litwin S; Eisenberg BL; Hoffman JP
Am Surg; 1997 Aug; 63(8):675-9; discussion 679-80. PubMed ID: 9247432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
